India's Wockhardt up after drug found effective in meningitis case
** Shares of Wockhardt Ltd WCKH.NS rise as much as 5% to
1,005.70 rupees
** Pharma co says its investigational drug Zaynich cures
complex case of meningitis in a 64-year-old patient
** Co says drug has treated over 35 critically ill patients
in India and US in the past year
** Stock on track to snap 3 days of losses
** More than 232,000 shares traded as of 1:36 p.m. IST,
busiest day in more than a week
** Stock gained 137% YTD
(Reporting by Meenakshi Maidas in Bengaluru)
((meenakshi.maidas@thomsonreuters.com;))
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter